Anand ,Uttpal ,G e .2024 .n e s & D i s e a s e s , v o l . 1 1 , n o . 4 , J u l y 2 0 2 4. , 101211 : 1367-1401.
Yi ,Wenzhe .2023 .Smart drug delivery systems to overcome drug resistance in cancer immunotherapy. ” Cancer Biology & Medicine, 0009(4) : 3941-267.
Fulton Melody D.,Wided Melody D.,April 2023 . .“Liposomes in cancer therapy: How did we start and where are we now. International Journal of Molecular Sciences, 24(7) : .
Hung Chih,Chiang Chih .2020 .The efficacy of pegylated liposomal doxorubicin-based neoadjuvant chemotherapy in breast cancer: A retrospective case-control study in Taiwan.” Biochemistry Research I n t e r n a t i o n a l , v o l . 2 0 2 0 , A p r i l 2 0 2 0. , : 1-9.
Xu ,Aoshu .2021 .Progressive study on the non-thermal effects of magnetic field therapy in oncology. , 638146 : .
Volodimirovich Movchan,Oleksii Movchan . .Advanced chemoresistant luminal B breast cancer patients' treatment improvement by a combination of liposomal pegylated doxorubicin and local Magnetothermy (regional inductive mild hyperthermia) compared to dose-dense therapy and local Magnetothermy (regional inductive mild hyperthermia).” International Journal of Chemical and Biochemical S c i e n c e s , v o l . 2 4 , n o . 6 , 2 0 2 3. , 5 9 7 - 6 0 : .
NCCN .2024 .Guidelines for Treatment of Cancer by Type. Breast Cancer. Version 4, : .
Syvak L .2017 .Magnetothermy of malignant neoplasms. ” Clinicaloncology, 2(26) : 66-70.
Matikas ,Alexios .2024 ./improved-survival-for-breast-cancer-patients-withdose-dense-chemotherapy. ” Journal of Clinical Oncology, 42(26) : 3077-3082.
Decker .2019 .Victoria: A randomised phase ii study to compare vinorelbine in combination with the mtor inhibitor everolimus versus vinorelbine monotherapy for second-line chemotherapy in advanced her2-negative breast cancer. ” Breast Cancer Research and Treatment, 176(3) : 637-647.
Nel ,Janske .2022 .Functionalized liposomes for targeted breast cancer drug delivery. ” Bioactive Materials, 12 : 401-437.
Kaur ,Ishdeep ,April 2023 . .Combination of chemotherapy and mild hyperthermia using targeted nanoparticles: A potential treatment modality for breast cancer. ” Pharmaceutics, 15(5) : .